Related references
Note: Only part of the references are listed.The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer
Stephen Safe et al.
MOLECULAR CANCER RESEARCH (2021)
The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells
Rupesh Shrestha et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Flavonoids: structure-function and mechanisms of action and opportunities for drug development
Stephen Safe et al.
TOXICOLOGICAL RESEARCH (2021)
Flavonoids as anticancer therapies: A systematic review of clinical trials
Angela Bisol et al.
PHYTOTHERAPY RESEARCH (2020)
Potential of phytochemicals as immune-regulatory compounds in atopic diseases: A review
Sukriti Sharma et al.
BIOCHEMICAL PHARMACOLOGY (2020)
The Coming Age of Flavonoids in the Treatment of Diabetic Complications
Teresa Caro-Ordieres et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Flavonoids as Anticancer Agents
Dalia M. Kopustinskiene et al.
NUTRIENTS (2020)
Long-term dietary flavonoid intake and risk of Alzheimer disease and related dementias in the Framingham Offspring Cohort
Esra Shishtar et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
Esra Shishtar et al.
JOURNAL OF NUTRITION (2020)
Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma
Akshay Bhat et al.
CANCER RESEARCH (2019)
Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2
Xi Li et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer
Kumaravel Mohankumar et al.
GYNECOLOGIC ONCOLOGY (2019)
Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
Chiara Focaccetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds
Hassan Abbaszadeh et al.
PHYTOTHERAPY RESEARCH (2019)
Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma
Erik Hedrick et al.
MOLECULAR CANCER RESEARCH (2019)
Anti-inflammatory effects of flavonoids
Soheila J. Maleki et al.
FOOD CHEMISTRY (2019)
New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
Yanfei Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway
Kai Wang et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma
Alexandra Lacey et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells
Tae Woo Kim et al.
CELL DEATH & DISEASE (2018)
PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1
Alexandra Lacey et al.
CANCER RESEARCH (2017)
Dietary total flavonoids intake and risk of mortality from all causes and cardiovascular disease in the general population: A systematic review and meta-analysis of cohort studies
Xue-ming Liu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Anticancer Efficacy of Polyphenols and Their Combinations
Aleksandra Niedzwiecki et al.
NUTRIENTS (2016)
Isoflavones: Anti-Inflammatory Benefit and Possible Caveats
Jie Yu et al.
NUTRIENTS (2016)
Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)
Alexandra Lacey et al.
ONCOTARGET (2016)
Flavonoids: an overview
A. N. Panche et al.
JOURNAL OF NUTRITIONAL SCIENCE (2016)
Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy
Erik Hedrick et al.
ENDOCRINE-RELATED CANCER (2015)
Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma
Erik Hedrick et al.
PLOS ONE (2015)
NR4A nuclear receptors are orphans but not lonesome
Kondababu Kurakula et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Diindolylmethane Analogs Bind NR4A1 and Are NR4A1 Antagonists in Colon Cancer Cells
Syng-Ook Lee et al.
MOLECULAR ENDOCRINOLOGY (2014)
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Melissa M. Hudson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis
Amy D. Marshall et al.
SKELETAL MUSCLE (2012)
Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease
Michael A. Pearen et al.
MOLECULAR ENDOCRINOLOGY (2010)
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
Stephen Safe et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer
Gabriele D. Maurer et al.
CLINICAL CANCER RESEARCH (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Fluorescent dyes as probes to study lipid-binding proteins
AV Pastukhov et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - A report from the intergroup rhabdomyosarcoma study IV
JC Breneman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)